Skip to main content

Performance of high-throughput CometChip assay using primary human hepatocytes: a comparison of DNA damage responses with in vitro human hepatoma cell lines

Abstract

Primary human hepatocytes (PHHs) are considered the “gold standard” for evaluating hepatic metabolism and toxicity of xenobiotics. In the present study, we evaluated the genotoxic potential of four indirect-acting (requiring metabolic activation) and six direct-acting genotoxic carcinogens, one aneugen, and five non-carcinogens that are negative or equivocal for genotoxicity in vivo in cryopreserved PHHs derived from three individual donors. DNA damage was determined over a wide range of concentrations using the CometChip technology and the resulting dose–responses were quantified using benchmark dose (BMD) modeling. Following a 24-h treatment, nine out of ten genotoxic carcinogens produced positive responses in PHHs, while negative responses were found for hydroquinone, aneugen colchicine and five non-carcinogens. Overall, PHHs demonstrated a higher sensitivity (90%) for detecting DNA damage from genotoxic carcinogens than the sensitivities previously reported for HepG2 (60%) and HepaRG (70%) cells. Quantitative analysis revealed that most of the compounds produced comparable BMD10 values among the three types of hepatocytes, while PHHs and HepaRG cells produced similar BMD1SD values. Evidence of sex- and ethnicity-related interindividual variation in DNA damage responses was also observed in the PHHs. A literature search for in vivo Comet assay data conducted in rodent liver tissues demonstrated consistent positive/negative calls for the compounds tested between in vitro PHHs and in vivo animal models. These results demonstrate that CometChip technology can be applied using PHHs for human risk assessment and that PHHs had higher sensitivity than HepaRG cells for detecting genotoxic carcinogens in the CometChip assay.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  • Antherieu S, Chesne C, Li R et al (2010) Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells. Drug Metab Dispos 38(3):516–525

    CAS  Article  Google Scholar 

  • Bowen DE, Whitwell JH, Lillford L et al (2011) Evaluation of a multi-endpoint assay in rats, combining the bone-marrow micronucleus test, the Comet assay and the flow-cytometric peripheral blood micronucleus test. Mutat Res 722(1):7–19

    CAS  Article  Google Scholar 

  • Dierks EA, Stams KR, Lim HK, Cornelius G, Zhang H, Ball SE (2001) A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry. Drug Metab Dispos 29(1):23–29

    CAS  PubMed  Google Scholar 

  • Gerets HH, Tilmant K, Gerin B et al (2012) Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol Toxicol 28(2):69–87

    CAS  Article  Google Scholar 

  • Guo X, Heflich RH, Dial SL, Richter PA, Moore MM, Mei N (2016) Quantitative analysis of the relative mutagenicity of five chemical constituents of tobacco smoke in the mouse lymphoma assay. Mutagenesis 31(3):287–296

    CAS  Article  Google Scholar 

  • Guo X, Mei N (2018) Benchmark dose modeling of in vitro genotoxicity data: a reanalysis. Toxicol Res 34(4):303–310

    CAS  Article  Google Scholar 

  • Guo X, Seo JE, Bryce SM et al (2018) Comparative genotoxicity of TEMPO and 3 of its derivatives in mouse lymphoma cells. Toxicol Sci 163(1):214–225

    CAS  Article  Google Scholar 

  • Guo X, Seo JE, Li X, Mei N (2020) Genetic toxicity assessment using liver cell models: past, present, and future. J Toxicol Environ Health B Crit Rev 23(1):27–50

    CAS  Article  Google Scholar 

  • Hong YH, Jeon HL, Ko KY et al (2018) Assessment of the predictive capacity of the optimized in vitro comet assay using HepG2 cells. Mutat Res Genet Toxicol Environ Mutagen 827:59–67

    CAS  Article  Google Scholar 

  • ICH (2011) Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use S2(R1). ICH Expert Working Group. https://database.ich.org/sites/default/files/S2_R1_Guideline.pdf. Accessed 23 Mar 2020

  • Kammerer S, Küpper J-H (2018) Human hepatocyte systems for in vitro toxicology analysis. J Cell Biotechnol 3(2):85–93

    Article  Google Scholar 

  • Khoury L, Zalko D, Audebert M (2016) Evaluation of four human cell lines with distinct biotransformation properties for genotoxic screening. Mutagenesis 31(1):83–96

    CAS  PubMed  Google Scholar 

  • Kirkland D, Pfuhler S, Tweats D et al (2007) How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: report of an ECVAM Workshop. Mutat Res 628(1):31–55

    CAS  Article  Google Scholar 

  • Koppen G, Azqueta A, Pourrut B, Brunborg G, Collins AR, Langie SAS (2017) The next three decades of the comet assay: a report of the 11th International Comet Assay Workshop. Mutagenesis 32(3):397–408

    CAS  Article  Google Scholar 

  • Lamba V, Lamba J, Yasuda K et al (2003) Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression. J Pharmacol Exp Ther 307(3):906–922

    CAS  Article  Google Scholar 

  • Le Hegarat L, Mourot A, Huet S et al (2014) Performance of comet and micronucleus assays in metabolic competent HepaRG cells to predict in vivo genotoxicity. Toxicol Sci 138(2):300–309

    Article  Google Scholar 

  • Mandon M, Huet S, Dubreil E, Fessard V, Le Hegarat L (2019) Three-dimensional HepaRG spheroids as a liver model to study human genotoxicity in vitro with the single cell gel electrophoresis assay. Sci Rep 9(1):10548

    Article  Google Scholar 

  • Misik M, Nersesyan A, Ropek N, Huber WW, Haslinger E, Knasmueller S (2019) Use of human derived liver cells for the detection of genotoxins in comet assays. Mutat Res 845:402995

    Article  Google Scholar 

  • OECD (2015) Guidance document on revisions to OECD genetic toxicology test guidelines. OECD Workgroup of National Coordinators for Test 42 Guidelines (WNT). https://www.oecd.org/chemicalsafety/testing/Genetic%20Toxicology%20Guidance%20Document%20Aug%2031%202015.pdf. Accessed 23 Mar 2020

  • OEHHA (2015) Diaminotoluenes (DATs). The Office of Environmental Health Hazard Assessment (OEHHA). https://oehha.ca.gov/media/downloads/proposition-65/chemicals/082815diaminotolueneshid.pdf. Accessed 23 Mar 2020

  • Oshida K, Iwanaga E, Miyamoto-Kuramitsu K, Miyamoto Y (2008) An in vivo comet assay of multiple organs (liver, kidney and bone marrow) in mice treated with methyl methanesulfonate and acetaminophen accompanied by hematology and/or blood chemistry. J Toxicol Sci 33(5):515–524

    CAS  Article  Google Scholar 

  • Parkinson A, Mudra DR, Johnson C, Dwyer A, Carroll KM (2004) The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol Appl Pharmacol 199(3):193–209

    CAS  Article  Google Scholar 

  • Sasaki YF, Nishidate E, Izumiyama F, Matsusaka N, Tsuda S (1997) Simple detection of chemical mutagens by the alkaline single-cell gel electrophoresis (Comet) assay in multiple mouse organs (liver, lung, spleen, kidney, and bone marrow). Mutat Res 391(3):215–231

    CAS  Article  Google Scholar 

  • Sekihashi K, Sasaki T, Yamamoto A et al (2001) A comparison of intraperitoneal and oral gavage administration in comet assay in mouse eight organs. Mutat Res 493(1–2):39–54

    CAS  Article  Google Scholar 

  • Sekihashi K, Yamamoto A, Matsumura Y et al (2002) Comparative investigation of multiple organs of mice and rats in the comet assay. Mutat Res 517(1–2):53–75

    CAS  Article  Google Scholar 

  • Seo JE, Tryndyak V, Wu Q et al (2019) Quantitative comparison of in vitro genotoxicity between metabolically competent HepaRG cells and HepG2 cells using the high-throughput high-content CometChip assay. Arch Toxicol 93(5):1433–1448

    CAS  Article  Google Scholar 

  • Speit G, Kojima H, Burlinson B et al (2015) Critical issues with the in vivo comet assay: a report of the comet assay working group in the 6th International Workshop on Genotoxicity Testing (IWGT). Mutat Res Genet Toxicol Environ Mutagen 783:6–12

    CAS  Article  Google Scholar 

  • Tascher G, Burban A, Camus S et al (2019) In-depth proteome analysis highlights HepaRG cells as a versatile cell system surrogate for primary human hepatocytes. Cells 8:2

    Article  Google Scholar 

  • Tsuda S, Matsusaka N, Madarame H et al (2000) The alkaline single cell electrophoresis assay with eight mouse organs: results with 22 mono-functional alkylating agents (including 9 dialkyl N-nitrosoamines) and 10 DNA crosslinkers. Mutat Res 467(1):83–98

    CAS  Article  Google Scholar 

  • Uno Y, Kojima H, Omori T et al (2015) JaCVAM-organized international validation study of the in vivo rodent alkaline comet assay for detection of genotoxic carcinogens: II. Summary of definitive validation study results. Mutat Res Genet Toxicol Environ Mutagen 786–788:45–76

    Article  Google Scholar 

  • Wilkening S, Stahl F, Bader A (2003) Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab Dispos 31(8):1035–1042

    CAS  Article  Google Scholar 

  • Wills JW, Johnson GE, Battaion HL, Slob W, White PA (2017) Comparing BMD-derived genotoxic potency estimations across variants of the transgenic rodent gene mutation assay. Environ Mol Mutagen 58(9):632–643

    CAS  Article  Google Scholar 

  • Zeilinger K, Freyer N, Damm G, Seehofer D, Knospel F (2016) Cell sources for in vitro human liver cell culture models. Exp Biol Med (Maywood) 241(15):1684–1698

    CAS  Article  Google Scholar 

  • Zeller A, Duran-Pacheco G, Guerard M (2017) An appraisal of critical effect sizes for the benchmark dose approach to assess dose–response relationships in genetic toxicology. Arch Toxicol 91(12):3799–3807

    CAS  Article  Google Scholar 

Download references

Acknowledgements

J.E.S. was supported by appointments to the Postgraduate Research Program at the National Center for Toxicological Research (NCTR) administered by the Oak Ridge Institute for Science Education (ORISE) through an interagency agreement between the U.S. Department of Energy and the U.S. Food and Drug Administration (FDA). We thank Drs. Dayton Petibone and Xilin Li for their critical review of this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiaoqing Guo.

Ethics declarations

Conflict of interest

There was no conflict of interest declared.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The information in this paper is not a formal dissemination of information by the U.S. FDA and does not represent the agency position or policy.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 630 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Seo, JE., Wu, Q., Bryant, M. et al. Performance of high-throughput CometChip assay using primary human hepatocytes: a comparison of DNA damage responses with in vitro human hepatoma cell lines. Arch Toxicol 94, 2207–2224 (2020). https://doi.org/10.1007/s00204-020-02736-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-020-02736-z

Keywords

  • CometChip assay
  • Primary human hepatocytes
  • HepaRG cells
  • HepG2 cells
  • Benchmark dose